GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $41,000 | 0.0% | 943 | +1.2% | 0.02% | +21.4% |
| Q1 2022 | $41,000 | +17.1% | 932 | +2.5% | 0.01% | +16.7% |
| Q3 2021 | $35,000 | -2.8% | 909 | +1.2% | 0.01% | -7.7% |
| Q2 2021 | $36,000 | +12.5% | 898 | +1.7% | 0.01% | 0.0% |
| Q1 2021 | $32,000 | 0.0% | 883 | +1.4% | 0.01% | 0.0% |
| Q4 2020 | $32,000 | 0.0% | 871 | +1.3% | 0.01% | -7.1% |
| Q3 2020 | $32,000 | -25.6% | 860 | -19.2% | 0.01% | -30.0% |
| Q2 2020 | $43,000 | +19.4% | 1,064 | +11.9% | 0.02% | +11.1% |
| Q1 2020 | $36,000 | -26.5% | 951 | -8.6% | 0.02% | -21.7% |
| Q4 2019 | $49,000 | +11.4% | 1,040 | +1.1% | 0.02% | 0.0% |
| Q3 2019 | $44,000 | +7.3% | 1,029 | +1.2% | 0.02% | +9.5% |
| Q2 2019 | $41,000 | -2.4% | 1,017 | +1.5% | 0.02% | -8.7% |
| Q1 2019 | $42,000 | +2.4% | 1,002 | -5.5% | 0.02% | 0.0% |
| Q4 2018 | $41,000 | -21.2% | 1,060 | -17.6% | 0.02% | -11.5% |
| Q3 2018 | $52,000 | +2.0% | 1,287 | +0.8% | 0.03% | -3.7% |
| Q2 2018 | $51,000 | -1.9% | 1,277 | -3.1% | 0.03% | -10.0% |
| Q1 2018 | $52,000 | +2.0% | 1,318 | -8.2% | 0.03% | -3.2% |
| Q4 2017 | $51,000 | -5.6% | 1,436 | +8.7% | 0.03% | -11.4% |
| Q3 2017 | $54,000 | -3.6% | 1,321 | +0.8% | 0.04% | 0.0% |
| Q2 2017 | $56,000 | +19.1% | 1,310 | +16.8% | 0.04% | +16.7% |
| Q1 2017 | $47,000 | +9.3% | 1,122 | +1.0% | 0.03% | 0.0% |
| Q4 2016 | $43,000 | -8.5% | 1,111 | +1.0% | 0.03% | -21.1% |
| Q3 2016 | $47,000 | 0.0% | 1,100 | +1.0% | 0.04% | -33.3% |
| Q2 2016 | $47,000 | +9.3% | 1,089 | +2.6% | 0.06% | -17.4% |
| Q1 2016 | $43,000 | +2.4% | 1,061 | +1.2% | 0.07% | +43.8% |
| Q4 2015 | $42,000 | +5.0% | 1,048 | +1.5% | 0.05% | -17.2% |
| Q3 2015 | $40,000 | -4.8% | 1,033 | +1.4% | 0.06% | +152.2% |
| Q2 2015 | $42,000 | -95.6% | 1,019 | -95.1% | 0.02% | -95.9% |
| Q1 2015 | $955,000 | -81.0% | 20,689 | -81.0% | 0.56% | -82.7% |
| Q3 2014 | $5,015,000 | +11297.7% | 109,101 | +13188.8% | 3.22% | +12269.2% |
| Q2 2014 | $44,000 | +2.3% | 821 | +1.5% | 0.03% | -3.7% |
| Q1 2014 | $43,000 | – | 809 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |